APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Synthesis Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gene Synthesis Software Market Analysis and Forecast 2026-2032

4 January 2026209 pages

Choose your research edition.

Industry ResearchGene Synthesis Software Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Synthesis Software Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Gene Synthesis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Synthesis Software Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Synthesis Software Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Gene Synthesis Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gene Synthesis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gene Synthesis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gene Synthesis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gene Synthesis Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gene Synthesis Software include Eurofins Genomics, ATUM, Biotage, Bioneer Corporation, Eurogentec, GenScript, GENEWIZ, Integrated DNA Technologies and OriGene Technologies, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gene Synthesis Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gene Synthesis Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Gene Synthesis Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Synthesis Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Synthesis Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gene Synthesis Software revenue, projected growth trends, production technology, application and end-user industry.

Gene Synthesis Software Segment by Company

Eurofins Genomics

ATUM

Biotage

Bioneer Corporation

Eurogentec

GenScript

GENEWIZ

Integrated DNA Technologies

OriGene Technologies

Thermo Fisher Scientific

Bio Basic

Twist Bioscience

BioCat GmbH

ProteoGenix

Charles River

Biosearch Technologies

Beijing SBS Genetech

Eton Bioscience

Gene Synthesis Software Segment by Type

Solid Phase Synthesis

Chip-based DNA Synthesis

PCR-based Enzyme Synthesis

Gene Synthesis Software Segment by Application

Academic and Research Institutes

Biotech and Pharmaceutical

Diagnostic Laboratories

Others

Gene Synthesis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gene Synthesis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gene Synthesis Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Synthesis Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Synthesis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Solid Phase Synthesis Major Player Table 3. Chip-based DNA Synthesis Major Player Table 4. PCR-based Enzyme Synthesis Major Player Table 5. Global Gene Synthesis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Academic and Research Institutes Major Player Table 7. Biotech and Pharmaceutical Major Player Table 8. Diagnostic Laboratories Major Player Table 9. Others Major Player Table 10. Gene Synthesis Software Industry Trends Table 11. Gene Synthesis Software Industry Drivers Table 12. Gene Synthesis Software Industry Opportunities and Challenges Table 13. Gene Synthesis Software Industry Restraints Table 14. Global Gene Synthesis Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Gene Synthesis Software Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Gene Synthesis Software Market Share by Region (2021-2026) Table 17. Global Gene Synthesis Software Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Gene Synthesis Software Market Share by Region (2027-2032) Table 19. Global Gene Synthesis Software Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Gene Synthesis Software Revenue Market Share by Players (2021-2026) Table 21. Global Gene Synthesis Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Gene Synthesis Software Key Players Headquarters & Area Served Table 23. Global Gene Synthesis Software Players, Product Type & Application Table 24. Global Gene Synthesis Software Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Gene Synthesis Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Gene Synthesis Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Gene Synthesis Software Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Gene Synthesis Software Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Gene Synthesis Software Revenue Market Share by Type (2021-2026) Table 31. Global Gene Synthesis Software Revenue Market Share by Type (2027-2032) Table 32. Global Gene Synthesis Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Gene Synthesis Software Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Gene Synthesis Software Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Gene Synthesis Software Revenue Market Share by Application (2021-2026) Table 36. Global Gene Synthesis Software Revenue Market Share by Application (2027-2032) Table 37. Eurofins Genomics Company Information Table 38. Eurofins Genomics Business Overview Table 39. Eurofins Genomics Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Eurofins Genomics Gene Synthesis Software Product Portfolio Table 41. Eurofins Genomics Recent Development Table 42. ATUM Company Information Table 43. ATUM Business Overview Table 44. ATUM Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. ATUM Gene Synthesis Software Product Portfolio Table 46. ATUM Recent Development Table 47. Biotage Company Information Table 48. Biotage Business Overview Table 49. Biotage Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Biotage Gene Synthesis Software Product Portfolio Table 51. Biotage Recent Development Table 52. Bioneer Corporation Company Information Table 53. Bioneer Corporation Business Overview Table 54. Bioneer Corporation Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Bioneer Corporation Gene Synthesis Software Product Portfolio Table 56. Bioneer Corporation Recent Development Table 57. Eurogentec Company Information Table 58. Eurogentec Business Overview Table 59. Eurogentec Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Eurogentec Gene Synthesis Software Product Portfolio Table 61. Eurogentec Recent Development Table 62. GenScript Company Information Table 63. GenScript Business Overview Table 64. GenScript Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. GenScript Gene Synthesis Software Product Portfolio Table 66. GenScript Recent Development Table 67. GENEWIZ Company Information Table 68. GENEWIZ Business Overview Table 69. GENEWIZ Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. GENEWIZ Gene Synthesis Software Product Portfolio Table 71. GENEWIZ Recent Development Table 72. Integrated DNA Technologies Company Information Table 73. Integrated DNA Technologies Business Overview Table 74. Integrated DNA Technologies Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Integrated DNA Technologies Gene Synthesis Software Product Portfolio Table 76. Integrated DNA Technologies Recent Development Table 77. OriGene Technologies Company Information Table 78. OriGene Technologies Business Overview Table 79. OriGene Technologies Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. OriGene Technologies Gene Synthesis Software Product Portfolio Table 81. OriGene Technologies Recent Development Table 82. Thermo Fisher Scientific Company Information Table 83. Thermo Fisher Scientific Business Overview Table 84. Thermo Fisher Scientific Gene Synthesis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Thermo Fisher Scientific Gene Synthesis Software Product Portfolio Table 86. Thermo Fisher Scientific Recent Development Table 87. Bio Basic Company Information Table 88. Bio Basic Business Overview Table 89. Bio Basic Gene Synthesis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Bio Basic Gene Synthesis Software Product Portfolio Table 91. Bio Basic Recent Development Table 92. Twist Bioscience Company Information Table 93. Twist Bioscience Business Overview Table 94. Twist Bioscience Gene Synthesis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Twist Bioscience Gene Synthesis Software Product Portfolio Table 96. Twist Bioscience Recent Development Table 97. BioCat GmbH Company Information Table 98. BioCat GmbH Business Overview Table 99. BioCat GmbH Gene Synthesis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. BioCat GmbH Gene Synthesis Software Product Portfolio Table 101. BioCat GmbH Recent Development Table 102. ProteoGenix Company Information Table 103. ProteoGenix Business Overview Table 104. ProteoGenix Gene Synthesis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. ProteoGenix Gene Synthesis Software Product Portfolio Table 106. ProteoGenix Recent Development Table 107. Charles River Company Information Table 108. Charles River Business Overview Table 109. Charles River Gene Synthesis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Charles River Gene Synthesis Software Product Portfolio Table 111. Charles River Recent Development Table 112. Biosearch Technologies Company Information Table 113. Biosearch Technologies Business Overview Table 114. Biosearch Technologies Gene Synthesis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Biosearch Technologies Gene Synthesis Software Product Portfolio Table 116. Biosearch Technologies Recent Development Table 117. Beijing SBS Genetech Company Information Table 118. Beijing SBS Genetech Business Overview Table 119. Beijing SBS Genetech Gene Synthesis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Beijing SBS Genetech Gene Synthesis Software Product Portfolio Table 121. Beijing SBS Genetech Recent Development Table 122. Eton Bioscience Company Information Table 123. Eton Bioscience Business Overview Table 124. Eton Bioscience Gene Synthesis Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Eton Bioscience Gene Synthesis Software Product Portfolio Table 126. Eton Bioscience Recent Development Table 127. North America Gene Synthesis Software Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Gene Synthesis Software Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Gene Synthesis Software Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Gene Synthesis Software Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Gene Synthesis Software Revenue by Country (2021-2026) & (US$ Million) Table 133. North America Gene Synthesis Software Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe Gene Synthesis Software Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Gene Synthesis Software Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Gene Synthesis Software Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Gene Synthesis Software Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Gene Synthesis Software Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe Gene Synthesis Software Revenue by Country (US$ Million) & (2027-2032) Table 141. China Gene Synthesis Software Revenue by Type (2021-2026) & (US$ Million) Table 142. China Gene Synthesis Software Revenue by Type (2027-2032) & (US$ Million) Table 143. China Gene Synthesis Software Revenue by Application (2021-2026) & (US$ Million) Table 144. China Gene Synthesis Software Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Gene Synthesis Software Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Gene Synthesis Software Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Gene Synthesis Software Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Gene Synthesis Software Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Gene Synthesis Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Gene Synthesis Software Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia Gene Synthesis Software Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA Gene Synthesis Software Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Gene Synthesis Software Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Gene Synthesis Software Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA Gene Synthesis Software Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA Gene Synthesis Software Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA Gene Synthesis Software Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Gene Synthesis Software Image Figure 2. Global Gene Synthesis Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Synthesis Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. Solid Phase Synthesis Image Figure 5. Chip-based DNA Synthesis Image Figure 6. PCR-based Enzyme Synthesis Image Figure 7. Global Gene Synthesis Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gene Synthesis Software Market Size Share 2021 VS 2025 VS 2032 Figure 9. Academic and Research Institutes Image Figure 10. Biotech and Pharmaceutical Image Figure 11. Diagnostic Laboratories Image Figure 12. Others Image Figure 13. Global Gene Synthesis Software Market Size (US$ Million) & (2021-2032) Figure 14. Global Gene Synthesis Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Gene Synthesis Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Gene Synthesis Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Gene Synthesis Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Gene Synthesis Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Gene Synthesis Software Revenue Market Share by Type (2021-2032) Figure 21. Global Gene Synthesis Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Gene Synthesis Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Gene Synthesis Software Revenue Market Share by Application (2021-2032) Figure 24. North America Gene Synthesis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Gene Synthesis Software Revenue Share by Type (2021-2032) Figure 26. North America Gene Synthesis Software Revenue Share by Application (2021-2032) Figure 27. North America Gene Synthesis Software Revenue Share by Country (2021-2032) Figure 28. United States Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Gene Synthesis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Gene Synthesis Software Revenue Share by Type (2021-2032) Figure 33. Europe Gene Synthesis Software Revenue Share by Application (2021-2032) Figure 34. Europe Gene Synthesis Software Revenue Share by Country (2021-2032) Figure 35. Germany Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Gene Synthesis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Gene Synthesis Software Revenue Share by Type (2021-2032) Figure 45. China Gene Synthesis Software Revenue Share by Application (2021-2032) Figure 46. Asia Gene Synthesis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Gene Synthesis Software Revenue Share by Type (2021-2032) Figure 48. Asia Gene Synthesis Software Revenue Share by Application (2021-2032) Figure 49. Asia Gene Synthesis Software Revenue Share by Region (2021-2032) Figure 50. Japan Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Gene Synthesis Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Gene Synthesis Software Revenue Share by Type (2021-2032) Figure 58. SAMEA Gene Synthesis Software Revenue Share by Application (2021-2032) Figure 59. SAMEA Gene Synthesis Software Revenue Share by Country (2021-2032) Figure 60. Brazil Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Gene Synthesis Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Phase Synthesis
  • Chip-based DNA Synthesis
  • PCR-based Enzyme Synthesis
Applications
  • Academic and Research Institutes
  • Biotech and Pharmaceutical
  • Diagnostic Laboratories
  • Others
Companies covered
  • Eurofins Genomics
  • ATUM
  • Biotage
  • Bioneer Corporation
  • Eurogentec
  • GenScript
  • GENEWIZ
  • Integrated DNA Technologies
  • OriGene Technologies
  • Thermo Fisher Scientific
  • Bio Basic
  • Twist Bioscience
  • BioCat GmbH
  • ProteoGenix
  • Charles River
  • Biosearch Technologies
  • Beijing SBS Genetech
  • Eton Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gene Synthesis Software Market by Type
  3. 1.2.1 Global Gene Synthesis Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Solid Phase Synthesis
  5. 1.2.3 Chip-based DNA Synthesis
  6. 1.2.4 PCR-based Enzyme Synthesis
  7. 1.3 Gene Synthesis Software Market by Application
  8. 1.3.1 Global Gene Synthesis Software Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Academic and Research Institutes
  10. 1.3.3 Biotech and Pharmaceutical
  11. 1.3.4 Diagnostic Laboratories
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Gene Synthesis Software Market Dynamics
  1. 2.1 Gene Synthesis Software Industry Trends
  2. 2.2 Gene Synthesis Software Industry Drivers
  3. 2.3 Gene Synthesis Software Industry Opportunities and Challenges
  4. 2.4 Gene Synthesis Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gene Synthesis Software Market Perspective (2021-2032)
  2. 3.2 Global Gene Synthesis Software Growth Trends by Region
  3. 3.2.1 Global Gene Synthesis Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gene Synthesis Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Gene Synthesis Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gene Synthesis Software Revenue by Players
  2. 4.1.1 Global Gene Synthesis Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Gene Synthesis Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gene Synthesis Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gene Synthesis Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gene Synthesis Software Key Players Headquarters & Area Served
  7. 4.4 Global Gene Synthesis Software Players, Product Type & Application
  8. 4.5 Global Gene Synthesis Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gene Synthesis Software Market CR5 and HHI
  11. 4.6.3 2025 Gene Synthesis Software Tier 1, Tier 2, and Tier 3
5 Gene Synthesis Software Market Size by Type
  1. 5.1 Global Gene Synthesis Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Synthesis Software Revenue by Type (2021-2032)
  3. 5.3 Global Gene Synthesis Software Revenue Market Share by Type (2021-2032)
6 Gene Synthesis Software Market Size by Application
  1. 6.1 Global Gene Synthesis Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gene Synthesis Software Revenue by Application (2021-2032)
  3. 6.3 Global Gene Synthesis Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins Genomics
  2. 7.1.1 Eurofins Genomics Company Information
  3. 7.1.2 Eurofins Genomics Business Overview
  4. 7.1.3 Eurofins Genomics Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Genomics Gene Synthesis Software Product Portfolio
  6. 7.1.5 Eurofins Genomics Recent Developments
  7. 7.2 ATUM
  8. 7.2.1 ATUM Company Information
  9. 7.2.2 ATUM Business Overview
  10. 7.2.3 ATUM Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ATUM Gene Synthesis Software Product Portfolio
  12. 7.2.5 ATUM Recent Developments
  13. 7.3 Biotage
  14. 7.3.1 Biotage Company Information
  15. 7.3.2 Biotage Business Overview
  16. 7.3.3 Biotage Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Biotage Gene Synthesis Software Product Portfolio
  18. 7.3.5 Biotage Recent Developments
  19. 7.4 Bioneer Corporation
  20. 7.4.1 Bioneer Corporation Company Information
  21. 7.4.2 Bioneer Corporation Business Overview
  22. 7.4.3 Bioneer Corporation Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bioneer Corporation Gene Synthesis Software Product Portfolio
  24. 7.4.5 Bioneer Corporation Recent Developments
  25. 7.5 Eurogentec
  26. 7.5.1 Eurogentec Company Information
  27. 7.5.2 Eurogentec Business Overview
  28. 7.5.3 Eurogentec Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurogentec Gene Synthesis Software Product Portfolio
  30. 7.5.5 Eurogentec Recent Developments
  31. 7.6 GenScript
  32. 7.6.1 GenScript Company Information
  33. 7.6.2 GenScript Business Overview
  34. 7.6.3 GenScript Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 GenScript Gene Synthesis Software Product Portfolio
  36. 7.6.5 GenScript Recent Developments
  37. 7.7 GENEWIZ
  38. 7.7.1 GENEWIZ Company Information
  39. 7.7.2 GENEWIZ Business Overview
  40. 7.7.3 GENEWIZ Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GENEWIZ Gene Synthesis Software Product Portfolio
  42. 7.7.5 GENEWIZ Recent Developments
  43. 7.8 Integrated DNA Technologies
  44. 7.8.1 Integrated DNA Technologies Company Information
  45. 7.8.2 Integrated DNA Technologies Business Overview
  46. 7.8.3 Integrated DNA Technologies Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Integrated DNA Technologies Gene Synthesis Software Product Portfolio
  48. 7.8.5 Integrated DNA Technologies Recent Developments
  49. 7.9 OriGene Technologies
  50. 7.9.1 OriGene Technologies Company Information
  51. 7.9.2 OriGene Technologies Business Overview
  52. 7.9.3 OriGene Technologies Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 OriGene Technologies Gene Synthesis Software Product Portfolio
  54. 7.9.5 OriGene Technologies Recent Developments
  55. 7.10 Thermo Fisher Scientific
  56. 7.10.1 Thermo Fisher Scientific Company Information
  57. 7.10.2 Thermo Fisher Scientific Business Overview
  58. 7.10.3 Thermo Fisher Scientific Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Thermo Fisher Scientific Gene Synthesis Software Product Portfolio
  60. 7.10.5 Thermo Fisher Scientific Recent Developments
  61. 7.11 Bio Basic
  62. 7.11.1 Bio Basic Company Information
  63. 7.11.2 Bio Basic Business Overview
  64. 7.11.3 Bio Basic Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Bio Basic Gene Synthesis Software Product Portfolio
  66. 7.11.5 Bio Basic Recent Developments
  67. 7.12 Twist Bioscience
  68. 7.12.1 Twist Bioscience Company Information
  69. 7.12.2 Twist Bioscience Business Overview
  70. 7.12.3 Twist Bioscience Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Twist Bioscience Gene Synthesis Software Product Portfolio
  72. 7.12.5 Twist Bioscience Recent Developments
  73. 7.13 BioCat GmbH
  74. 7.13.1 BioCat GmbH Company Information
  75. 7.13.2 BioCat GmbH Business Overview
  76. 7.13.3 BioCat GmbH Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  77. 7.13.4 BioCat GmbH Gene Synthesis Software Product Portfolio
  78. 7.13.5 BioCat GmbH Recent Developments
  79. 7.14 ProteoGenix
  80. 7.14.1 ProteoGenix Company Information
  81. 7.14.2 ProteoGenix Business Overview
  82. 7.14.3 ProteoGenix Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  83. 7.14.4 ProteoGenix Gene Synthesis Software Product Portfolio
  84. 7.14.5 ProteoGenix Recent Developments
  85. 7.15 Charles River
  86. 7.15.1 Charles River Company Information
  87. 7.15.2 Charles River Business Overview
  88. 7.15.3 Charles River Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Charles River Gene Synthesis Software Product Portfolio
  90. 7.15.5 Charles River Recent Developments
  91. 7.16 Biosearch Technologies
  92. 7.16.1 Biosearch Technologies Company Information
  93. 7.16.2 Biosearch Technologies Business Overview
  94. 7.16.3 Biosearch Technologies Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Biosearch Technologies Gene Synthesis Software Product Portfolio
  96. 7.16.5 Biosearch Technologies Recent Developments
  97. 7.17 Beijing SBS Genetech
  98. 7.17.1 Beijing SBS Genetech Company Information
  99. 7.17.2 Beijing SBS Genetech Business Overview
  100. 7.17.3 Beijing SBS Genetech Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Beijing SBS Genetech Gene Synthesis Software Product Portfolio
  102. 7.17.5 Beijing SBS Genetech Recent Developments
  103. 7.18 Eton Bioscience
  104. 7.18.1 Eton Bioscience Company Information
  105. 7.18.2 Eton Bioscience Business Overview
  106. 7.18.3 Eton Bioscience Gene Synthesis Software Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Eton Bioscience Gene Synthesis Software Product Portfolio
  108. 7.18.5 Eton Bioscience Recent Developments
8 North America
  1. 8.1 North America Gene Synthesis Software Revenue (2021-2032)
  2. 8.2 North America Gene Synthesis Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Gene Synthesis Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Gene Synthesis Software Revenue by Type (2027-2032)
  5. 8.3 North America Gene Synthesis Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Gene Synthesis Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Gene Synthesis Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Gene Synthesis Software Revenue by Application (2027-2032)
  9. 8.5 North America Gene Synthesis Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Gene Synthesis Software Revenue by Country
  11. 8.6.1 North America Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gene Synthesis Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Gene Synthesis Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Gene Synthesis Software Revenue (2021-2032)
  2. 9.2 Europe Gene Synthesis Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gene Synthesis Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gene Synthesis Software Revenue by Type (2027-2032)
  5. 9.3 Europe Gene Synthesis Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gene Synthesis Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gene Synthesis Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gene Synthesis Software Revenue by Application (2027-2032)
  9. 9.5 Europe Gene Synthesis Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gene Synthesis Software Revenue by Country
  11. 9.6.1 Europe Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gene Synthesis Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gene Synthesis Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Gene Synthesis Software Revenue (2021-2032)
  2. 10.2 China Gene Synthesis Software Revenue by Type (2021-2032)
  3. 10.2.1 China Gene Synthesis Software Revenue by Type (2021-2026)
  4. 10.2.2 China Gene Synthesis Software Revenue by Type (2027-2032)
  5. 10.3 China Gene Synthesis Software Revenue Share by Type (2021-2032)
  6. 10.4 China Gene Synthesis Software Revenue by Application (2021-2032)
  7. 10.4.1 China Gene Synthesis Software Revenue by Application (2021-2026)
  8. 10.4.2 China Gene Synthesis Software Revenue by Application (2027-2032)
  9. 10.5 China Gene Synthesis Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gene Synthesis Software Revenue (2021-2032)
  2. 11.2 Asia Gene Synthesis Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gene Synthesis Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gene Synthesis Software Revenue by Type (2027-2032)
  5. 11.3 Asia Gene Synthesis Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gene Synthesis Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gene Synthesis Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gene Synthesis Software Revenue by Application (2027-2032)
  9. 11.5 Asia Gene Synthesis Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gene Synthesis Software Revenue by Country
  11. 11.6.1 Asia Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gene Synthesis Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gene Synthesis Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gene Synthesis Software Revenue (2021-2032)
  2. 12.2 SAMEA Gene Synthesis Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gene Synthesis Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gene Synthesis Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gene Synthesis Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gene Synthesis Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gene Synthesis Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gene Synthesis Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gene Synthesis Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gene Synthesis Software Revenue by Country
  11. 12.6.1 SAMEA Gene Synthesis Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gene Synthesis Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gene Synthesis Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst